Literature DB >> 1002838

Adenosquamous carcinoma of the endometrium.

M T Haqqani, H Fox.   

Abstract

An adenosquamous carcinoma of the endometrium is one which contains both malignant glandular and malignant squamous components; such tumours are considered rare in Britain but are thought to account for nearly one-third of all endometrial neoplasms in the United States. A survey of 675 cases of endometrial cancer seen during the period 1956-75 showed that the incidence of adenosquamous carcinoma was 5%, an incidence that remained static during this 20-year period. The principal difficulties encountered in the diagnosis of these neoplasms are in identifying the squamous component as such and in differentiating it from benign metaplastic squamous epithelium. The prognosis for patients with an endometrial adenosquamous carcinoma is very much worse than for women with a pure adenocarcinoma, and because these neoplasms are often wrongly identified it is possible that the currently accepted prognoses for both pure adenocarcinoma and adenoacanthoma of the endometrium may have to be revised. There appears to be a true variation in the incidence of this neoplasm between Britain and the United States.

Entities:  

Mesh:

Year:  1976        PMID: 1002838      PMCID: PMC476239          DOI: 10.1136/jcp.29.11.959

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  ENDOMETRIAL ADENOACANTHOMA; A CLINICOPATHOLOGICAL STUDY OF 55 CASES.

Authors:  D CHARLES
Journal:  Cancer       Date:  1965-06       Impact factor: 6.860

2.  Uterine adenoacanthoma.

Authors:  E R NOVAK; W B NALLEY
Journal:  Obstet Gynecol       Date:  1957-04       Impact factor: 7.661

3.  Increased risk of endometrial carcinoma among users of conjugated estrogens.

Authors:  H K Ziel; W D Finkle
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

4.  Calculation of survival rates for cancer.

Authors:  J BERKSON; R P GAGE
Journal:  Proc Staff Meet Mayo Clin       Date:  1950-05-24

5.  Cellular pathology and uterine cancer. Ward Burdick Award address.

Authors:  J W Reagan
Journal:  Am J Clin Pathol       Date:  1974-08       Impact factor: 2.493

6.  Mixed (adenosquamous) carcinoma of the endometrium: electron microscopic observations.

Authors:  M Aikawa; A B Ng
Journal:  Cancer       Date:  1973-02       Impact factor: 6.860

7.  Mixed adenosquamous carcinoma of the endometrium.

Authors:  A B Ng; J W Reagan; J P Storaasli; W B Wentz
Journal:  Am J Clin Pathol       Date:  1973-06       Impact factor: 2.493

8.  Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium. A clinicopathologic study.

Authors:  S G Silverberg; M G Bolin; L S DeGiorgi
Journal:  Cancer       Date:  1972-11       Impact factor: 6.860

9.  A study of endometrial adenocarcinoma with emphasis on morphologically variant types.

Authors:  C T Liu
Journal:  Am J Clin Pathol       Date:  1972-05       Impact factor: 2.493

10.  Association of exogenous estrogen and endometrial carcinoma.

Authors:  D C Smith; R Prentice; D J Thompson; W L Herrmann
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

View more
  4 in total

1.  Adenoacanthoma of the endometrium: a separate entity or a histological curiosity?

Authors:  H Barrowclough; K W Jaarsma
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

2.  Adenoacanthoma of the endometrium: morphological changes induced by human papillomavirus.

Authors:  W F Kealy; P G Annis; J A Barry; J M Hogan
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

3.  Prognostic criteria in patients with endometrial cancer.

Authors:  J Baltzer; K J Lohe; R Kuerzl; K P Scheer; J Zander
Journal:  Arch Gynecol       Date:  1983

4.  Adenosquamous carcinoma of vesicovaginal fistula: a rare entity.

Authors:  Rudresh Tabali; Aravind Ramkumar
Journal:  Case Rep Obstet Gynecol       Date:  2014-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.